Lexington-Fayette

Studies show that Viagra may help reduce the risk of Alzheimer’s disease – Lexington-Fayette, Kentucky

Lexington-Fayette, Kentucky 2021-12-07 08:34:31 –

Cleveland, Ohio. — Recent research led by Cleveland Clinic Viagra has been identified as a drug that may help treat and prevent Alzheimer’s disease.

The study showed that erectile dysfunction drug Viagra and sildenafil, a generic term for pulmonary hypertension, are associated with a 69% reduction in the risk of Alzheimer’s disease.

The research team used computational techniques to screen and validate FDA-approved drugs as possible treatments for Alzheimer’s disease, and to look at a database of more than 7 million patients.

The results indicate the need for follow-up testing of drug efficacy in sick patients.

According to the Cleveland Clinic, the disease is expected to affect 13.8 million Americans by 2050 without the development of effective new treatments.

Clinics add drug repositioning, including the use of existing drugs for new therapeutic purposes, providing a logical alternative to the often costly and time-consuming drug discovery process.

“This paper is an example of the growth of precision medicine research, where big data is key to linking existing drugs with complex diseases like Alzheimer’s disease,” said the translational program. The director, Dr. Janyuan, said. Bioinformatics and drug development at the National Institute on Aging (NIA), which is part of the National Institutes of Health (NIH) that funded this research. “This is one of many efforts we are helping to find safe compounds available for existing drugs or other conditions that are potential candidates for clinical trials of Alzheimer’s disease.”

Danielle Meadows of KMTV first reported this story.



Source link

Back to top button